V009-3937 Screening compound: [(4-tert-butylphenyl)methyl](3,3-diphenylpropyl){[4-(4-ethylpiperazine-1-carbonyl)-1,3-thiazol-2-yl]methyl}amine

V009-3937 Screening compound: [(4-tert-butylphenyl)methyl](3,3-diphenylpropyl){[4-(4-ethylpiperazine-1-carbonyl)-1,3-thiazol-2-yl]methyl}amine
V009-3937 Screening compound: [(4-tert-butylphenyl)methyl](3,3-diphenylpropyl){[4-(4-ethylpiperazine-1-carbonyl)-1,3-thiazol-2-yl]methyl}amine alternative view

Chemical Structure Depiction of ChemDiv screening compound V009-3937
[(4-tert-butylphenyl)methyl](3,3-diphenylpropyl){[4-(4-ethylpiperazine-1-carbonyl)-1,3-thiazol-2-yl]methyl}amine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V009-3937

Molecular Formula

C37H46N4OS (C37 H46 N4 OS)

Compound Name

[(4-tert-butylphenyl)methyl](3,3-diphenylpropyl){[4-(4-ethylpiperazine-1-carbonyl)-1,3-thiazol-2-yl]methyl}amine

IUPAC name

[(4-tert-butylphenyl)methyl](33-diphenylpropyl){[4-(4-ethylpiperazine-1-carbonyl)-13-thiazol-2-yl]methyl}amine

SMILES

CCN(CC1)CCN1C(c1csc(CN(CCC(c2ccccc2)c2ccccc2)Cc2ccc(C(C)(C)C)cc2)n1)=O

InChI

InChI=1S/C37H46N4OS/c1-5-39-22-24-41(25-23-39)36(42)34-28-43-35(38-34)27-40(26-29-16-18-32(19-17-29)37(2,3)4)21-20-33(30-12-8-6-9-13-30)31-14-10-7-11-15-31/h6-19,28,33H,5,20-27H2,1-4H3

InChI Key

OTVJFLWRVCVXRM-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19766665

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

594.86

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

7.576

Distribution Coefficient, logD

7.398

Water Solubility, LogSw

-5.71

Polar Surface Area

34.071

Acid Dissociation Constant (pKa)

24.26

Base Dissociation Constant (pKb)

7.10

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.50

V009-3937 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

GPCR Targeted Library (31838 compounds)

KRAS-Targeted Library (16000 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V009-3937 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V009-3937?
Check Price and Availability of V009-3937, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V009-3937 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V009-3937
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V009-3937
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V009-3937 available by request